Skip to main content
Signal8

Telesis Bio, Inc. (TBIO)

Telesis Bio, Inc., formerly known as Codex DNA, Inc. (and SGI-DNA, Inc. prior to that), is a San Diego, California-based synthetic biology company established in 2011. The company provides a comprehensive suite of instruments, reagents, and services for synthetic biology applications, catering primarily to pharmaceutical and academic laboratories worldwide. Its clientele also extends to government institutions, contract research organizations (CROs), and other synthetic biology enterprises. Among its core offerings is the BioXp system, a groundbreaking platform that empowers researchers to generate endpoint-ready synthetic DNA directly from digital sequences. Complementing this, the BioXp portal offers an intuitive online environment with guided workflows and design tools for constructing new DNA sequences and assembling them into desired vectors. For specific synthetic biology tasks, Telesis Bio supplies BioXp kits, which include essential building blocks and proprietary reagents like its well-known Gibson Assembly products. Additional solutions encompass cloud-based scripts and specialized benchtop reagents designed for post-BioXp system workflows. Through its Biofoundry Services, customers can commission and receive BioXp system-generated products, such as custom genes, clones, cell-free amplified DNA, and diverse variant libraries. The company also performs enzymatic DNA synthesis using short oligo ligation assembly techniques.

Sector: Medical - Devices

Industry: Medical - Devices

Telesis Bio, Inc. logo

Telesis Bio, Inc.

OTC:TBIOHealthcare
+0.00%$0.0100
CLOSED
Mkt Cap$784K
EV-
Float59.35M
O/S78.39M
VOL113 sh
$ Vol$1
RVOL0.20×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Telesis Bio, Inc. logoOTC:TBIOClosed$0.0100+0.00%
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 59.35M · FMP free float

176
Oct 30 (18d)prev 81▲ 117.3%
4.76
Oct 30 (18d)prev 1.00▲ 376.0%
Borrow (IBKR)

The cost to borrow TBIO shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 2026176 sh
Oct 15, 202681 sh
Sep 30, 2026176 sh
Sep 15, 2026176 sh
Aug 31, 2026176 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for TBIO: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 176 TBIO shares were sold short (<0.01% of a 59.35M-share float, 4.76 days to cover).